Ipamorelin + CJC-1295 – Oxy Peptide

Oxy Peptide Ipamorelin 5 mg + CJC-1295 5 mg is a premium dual-peptide research formulation combining Ipamorelin, a selective Growth Hormone Secretagogue (GHS), with CJC-1295, a Growth Hormone Releasing Hormone (GHRH) analogue. This advanced peptide blend is extensively studied for its complementary interaction with growth hormone signaling pathways, making it a valuable research tool for investigations involving endocrine physiology, peptide synergy, receptor biology, and cellular communication.

Presented in a lyophilized 10 mg vial, this high-purity formulation is manufactured to deliver exceptional stability, consistency, and reliability for advanced laboratory research. By combining two well-established research peptides into a single formulation, Oxy Peptide Ipamorelin + CJC-1295 provides researchers with an efficient platform for exploring hormone regulation, peptide pharmacology, metabolic physiology, and growth hormone-related biological pathways under controlled scientific conditions.

Produced under stringent quality standards, Oxy Peptide Ipamorelin + CJC-1295 is intended exclusively for laboratory and scientific research, delivering the purity and precision expected by professionals in modern peptide science.

Key Features

• Advanced dual-peptide research blend
• Combines Ipamorelin and CJC-1295 in one formulation
• Total peptide content: 10 mg per vial
• 1 lyophilized vial per pack
• High-purity research-grade formulation
• Commonly studied in growth hormone and endocrine pathway research
• Suitable for investigations involving peptide synergy, receptor signaling, hormone regulation, and cellular communication
• Manufactured under strict quality standards
• Intended exclusively for laboratory and scientific research applications

Contents

Active Ingredients:

• Ipamorelin – 5 mg
• CJC-1295 – 5 mg

Packaging: 1 Lyophilized Vial